Bankruptcy judge to approve plan dissolving OxyContin maker Purdue Pharma

OxyContin pills
(Image credit: AP Photo/Toby Talbot, File)

A bankruptcy judge said on Wednesday that if small changes are made to Purdue Pharma's bankruptcy reorganization plan, he will approve it. As it is now, the plan shields the company's owners, the Sackler family, from future lawsuits over its OxyContin product.

State and local governments, hospitals, and tribes have all sued Purdue and members of the Sackler family, and are among the creditors in the bankruptcy. OxyContin is an opioid that has a risk for addiction, and Judge Robert Drain on Wednesday said Purdue Pharma marketed it in a way that contributed to the country's opioid epidemic, which kills tens of thousands of Americans a year. "That makes the bankruptcy case before me highly unusual and complex," Drain stated.

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up
Explore More
Catherine Garcia, The Week US

Catherine Garcia has worked as a senior writer at The Week since 2014. Her writing and reporting have appeared in Entertainment Weekly, The New York Times, Wirecutter, NBC News and "The Book of Jezebel," among others. She's a graduate of the University of Redlands and the Columbia University Graduate School of Journalism.